지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
초록· 키워드
오류제보하기
Informed consent is the procedure that respects the autonomy of patients; doctors protect patients’choices and rights through informed consent. Competence and voluntariness are prerequisitefor the informed consent. In recent years, the necessity of informed consent from the Psychiatricdepartment has been raised. Regarding informed consent from the Psychiatric department,there is a need to consider from two perspectives: respect for the patient’s decisionmakingability and the psychiatrist’s legal self-protection. In competence and voluntariness,psychiatric patients were excluded due to lack of decision-making ability and willingness. However,not all psychiatric patients were able to perform the given task. Therefore, informed consentis needed in the point of view regarding the decision-making ability of psychiatric patients. Psychotropicmedications, particularly antipsychotics, can cause several side effects, including extrapyramidalsyndrome and metabolic syndrome. Therefore, preannouncement of these patientsfor these side effects is needed. However, when the informed consent is only applied to psychiatrichospitals, it may increase prejudices and misconceptions about psychiatric medications andtreatment. Therefore, the informed consent should first be considered carefully and thoughtfully.
목차
등록된 정보가 없습니다.
참고문헌 (30)
참고문헌 신청
/ / City and county of San Francisco Department of Public health / Sfdph.org
/ / Minimum Data Sets Quality Measure/Indicator Report / CMS.gov
/ / New Hampshire : US Food and Drug Administration ;2005 important drug warning and new information / FDA.gov
/ / New Hampshire : US Food and Drug Administration;2004 Safety Alert:Zyprexa(olanzapine) / FDA.gov
/ 1980 / 대법원 선고 79도1387 판결
/ / Minimum Data Sets Quality Measure/Indicator Report / CMS.gov
/ / New Hampshire : US Food and Drug Administration ;2005 important drug warning and new information / FDA.gov
/ / New Hampshire : US Food and Drug Administration;2004 Safety Alert:Zyprexa(olanzapine) / FDA.gov
/ 1980 / 대법원 선고 79도1387 판결
이 논문의 저자 정보
최근 본 자료
댓글(0)
0